Global Drug Eluting Balloons (DEB) Market Growth 2021-2026
According to this latest study, the 2021 growth of Drug Eluting Balloons (DEB) will have significant change from previous year. By the most conservative estimates of global Drug Eluting Balloons (DEB) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 499.9 million in 2020. Over the next five years the Drug Eluting Balloons (DEB) market will register a 13.6% CAGR in terms of revenue, the global market size will reach US$ 832.2 million by 2026._x000D_
_x000D_
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloons (DEB) market by product type, application, key manufacturers and key regions and countries._x000D_
_x000D_
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7._x000D_
Peripheral DEBs_x000D_
Coronary DEBs_x000D_
_x000D_
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8._x000D_
Catheterization Laboratory_x000D_
Hospital_x000D_
Others_x000D_
_x000D_
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8._x000D_
Americas_x000D_
United States_x000D_
Canada_x000D_
Mexico_x000D_
Brazil_x000D_
APAC_x000D_
China_x000D_
Japan_x000D_
Korea_x000D_
Southeast Asia_x000D_
India_x000D_
Australia_x000D_
Europe_x000D_
Germany_x000D_
France_x000D_
UK_x000D_
Italy_x000D_
Russia_x000D_
Middle East & Africa_x000D_
Egypt_x000D_
South Africa_x000D_
Israel_x000D_
Turkey_x000D_
GCC Countries_x000D_
_x000D_
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3._x000D_
B. Braun_x000D_
Medtronic_x000D_
Boston Scientific_x000D_
BD_x000D_
Yinyi_x000D_
Philips_x000D_
Eurocor_x000D_
Aachen Resonance_x000D_
Biotronic_x000D_
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report_x000D_
1.1 Market Introduction_x000D_
1.2 Years Considered_x000D_
1.3 Research Objectives_x000D_
1.4 Market Research Methodology_x000D_
1.5 Research Process and Data Source_x000D_
1.6 Economic Indicators_x000D_
1.7 Currency Considered_x000D_
_x000D_
2 Executive Summary_x000D_
2.1 World Market Overview_x000D_
2.1.1 Global Drug Eluting Balloons (DEB) Consumption 2016-2026_x000D_
2.1.2 Drug Eluting Balloons (DEB) Consumption CAGR by Region_x000D_
2.2 Drug Eluting Balloons (DEB) Segment by Type_x000D_
2.2.1 Peripheral DEBs_x000D_
2.2.2 Coronary DEBs_x000D_
2.3 Drug Eluting Balloons (DEB) Sales by Type_x000D_
2.3.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2016-2021)_x000D_
2.3.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Type (2016-2021)_x000D_
2.3.3 Global Drug Eluting Balloons (DEB) Sale Price by Type (2016-2021)_x000D_
2.4 Drug Eluting Balloons (DEB) Segment by Application_x000D_
2.4.1 Catheterization Laboratory_x000D_
2.4.2 Hospital_x000D_
2.4.3 Others_x000D_
2.5 Drug Eluting Balloons (DEB) Sales by Application_x000D_
2.5.1 Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2016-2021)_x000D_
2.5.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Application (2016-2021)_x000D_
2.5.3 Global Drug Eluting Balloons (DEB) Sale Price by Application (2016-2021)_x000D_
_x000D_
3 Global Drug Eluting Balloons (DEB) by Company_x000D_
3.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Company_x000D_
3.1.1 Global Drug Eluting Balloons (DEB) Sales by Company (2019-2021)_x000D_
3.1.2 Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2019-2021)_x000D_
3.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Company_x000D_
3.2.1 Global Drug Eluting Balloons (DEB) Revenue by Company (2019-2021)_x000D_
3.2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2019-2021)_x000D_
3.3 Global Drug Eluting Balloons (DEB) Sale Price by Company_x000D_
3.4 Global Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution, Sales Area, Product Type_x000D_
3.4.1 Key Manufacturers Drug Eluting Balloons (DEB) Product Location Distribution_x000D_
3.4.2 Players Drug Eluting Balloons (DEB) Products Offered_x000D_
3.5 Market Concentration Rate Analysis_x000D_
3.5.1 Competition Landscape Analysis_x000D_
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)_x000D_
3.6 New Products and Potential Entrants_x000D_
3.7 Mergers & Acquisitions, Expansion_x000D_
_x000D_
4 Drug Eluting Balloons (DEB) by Region_x000D_
4.1 Global Drug Eluting Balloons (DEB) by Region_x000D_
4.1.1 Global Drug Eluting Balloons (DEB) Sales by Region_x000D_
4.1.2 Global Drug Eluting Balloons (DEB) Revenue by Region_x000D_
4.2 Americas Drug Eluting Balloons (DEB) Sales Growth_x000D_
4.3 APAC Drug Eluting Balloons (DEB) Sales Growth_x000D_
4.4 Europe Drug Eluting Balloons (DEB) Sales Growth_x000D_
4.5 Middle East & Africa Drug Eluting Balloons (DEB) Sales Growth_x000D_
_x000D_
5 Americas_x000D_
5.1 Americas Drug Eluting Balloons (DEB) Sales by Country_x000D_
5.1.1 Americas Drug Eluting Balloons (DEB) Sales by Country (2016-2021)_x000D_
5.1.2 Americas Drug Eluting Balloons (DEB) Revenue by Country (2016-2021)_x000D_
5.2 Americas Drug Eluting Balloons (DEB) Sales by Type_x000D_
5.3 Americas Drug Eluting Balloons (DEB) Sales by Application_x000D_
5.4 United States_x000D_
5.5 Canada_x000D_
5.6 Mexico_x000D_
5.7 Brazil_x000D_
_x000D_
6 APAC_x000D_
6.1 APAC Drug Eluting Balloons (DEB) Sales by Region_x000D_
6.1.1 APAC Drug Eluting Balloons (DEB) Sales by Region (2016-2021)_x000D_
6.1.2 APAC Drug Eluting Balloons (DEB) Revenue by Region (2016-2021)_x000D_
6.2 APAC Drug Eluting Balloons (DEB) Sales by Type_x000D_
6.3 APAC Drug Eluting Balloons (DEB) Sales by Application_x000D_
6.4 China_x000D_
6.5 Japan_x000D_
6.6 Korea_x000D_
6.7 Southeast Asia_x000D_
6.8 India_x000D_
6.9 Australia_x000D_
_x000D_
7 Europe_x000D_
7.1 Europe Drug Eluting Balloons (DEB) by Country_x000D_
7.1.1 Europe Drug Eluting Balloons (DEB) Sales by Country (2016-2021)_x000D_
7.1.2 Europe Drug Eluting Balloons (DEB) Revenue by Country (2016-2021)_x000D_
7.2 Europe Drug Eluting Balloons (DEB) Sales by Type_x000D_
7.3 Europe Drug Eluting Balloons (DEB) Sales by Application_x000D_
7.4 Germany_x000D_
7.5 France_x000D_
7.6 UK_x000D_
7.7 Italy_x000D_
7.8 Russia_x000D_
_x000D_
8 Middle East & Africa_x000D_
8.1 Middle East & Africa Drug Eluting Balloons (DEB) by Country_x000D_
8.1.1 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2016-2021)_x000D_
8.1.2 Middle East & Africa Drug Eluting Balloons (DEB) Revenue by Country (2016-2021)_x000D_
8.2 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type_x000D_
8.3 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application_x000D_
8.4 Egypt_x000D_
8.5 South Africa_x000D_
8.6 Israel_x000D_
8.7 Turkey_x000D_
8.8 GCC Country_x000D_
_x000D_
9 Market Drivers, Challenges and Trends_x000D_
9.1 Market Drivers and Impact_x000D_
9.1.1 Growing Demand from Key Regions_x000D_
9.1.2 Growing Demand from Key Applications and Potential Industries_x000D_
9.2 Market Challenges and Impact_x000D_
9.3 Market Trends_x000D_
_x000D_
10 Marketing, Distributors and Customer_x000D_
10.1 Sales Channel_x000D_
10.1.1 Direct Channels_x000D_
10.1.2 Indirect Channels_x000D_
10.2 Drug Eluting Balloons (DEB) Distributors_x000D_
10.3 Drug Eluting Balloons (DEB) Customer_x000D_
_x000D_
11 Global Drug Eluting Balloons (DEB) Market Forecast_x000D_
11.1 Global Drug Eluting Balloons (DEB) Forecast by Region_x000D_
11.1.1 Global Drug Eluting Balloons (DEB) Forecast by Regions (2021-2026)_x000D_
11.2.2 Global Drug Eluting Balloons (DEB) Revenue Forecast by Regions (2021-2026)_x000D_
11.2 Americas Forecast by Country_x000D_
11.3 APAC Forecast by Region_x000D_
11.4 Europe Forecast by Country_x000D_
11.5 Middle East & Africa Forecast by Country_x000D_
11.6 Global Drug Eluting Balloons (DEB) Forecast by Type_x000D_
11.7 Global Drug Eluting Balloons (DEB) Forecast by Application_x000D_
_x000D_
12 Key Players Analysis_x000D_
12.1 B. Braun_x000D_
12.1.1 B. Braun Company Information_x000D_
12.1.2 B. Braun Drug Eluting Balloons (DEB) Product Offered_x000D_
12.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.1.4 B. Braun Main Business Overview_x000D_
12.1.5 B. Braun Latest Developments_x000D_
12.2 Medtronic_x000D_
12.2.1 Medtronic Company Information_x000D_
12.2.2 Medtronic Drug Eluting Balloons (DEB) Product Offered_x000D_
12.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.2.4 Medtronic Main Business Overview_x000D_
12.2.5 Medtronic Latest Developments_x000D_
12.3 Boston Scientific_x000D_
12.3.1 Boston Scientific Company Information_x000D_
12.3.2 Boston Scientific Drug Eluting Balloons (DEB) Product Offered_x000D_
12.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.3.4 Boston Scientific Main Business Overview_x000D_
12.3.5 Boston Scientific Latest Developments_x000D_
12.4 BD_x000D_
12.4.1 BD Company Information_x000D_
12.4.2 BD Drug Eluting Balloons (DEB) Product Offered_x000D_
12.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.4.4 BD Main Business Overview_x000D_
12.4.5 BD Latest Developments_x000D_
12.5 Yinyi_x000D_
12.5.1 Yinyi Company Information_x000D_
12.5.2 Yinyi Drug Eluting Balloons (DEB) Product Offered_x000D_
12.5.3 Yinyi Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.5.4 Yinyi Main Business Overview_x000D_
12.5.5 Yinyi Latest Developments_x000D_
12.6 Philips_x000D_
12.6.1 Philips Company Information_x000D_
12.6.2 Philips Drug Eluting Balloons (DEB) Product Offered_x000D_
12.6.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.6.4 Philips Main Business Overview_x000D_
12.6.5 Philips Latest Developments_x000D_
12.7 Eurocor_x000D_
12.7.1 Eurocor Company Information_x000D_
12.7.2 Eurocor Drug Eluting Balloons (DEB) Product Offered_x000D_
12.7.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.7.4 Eurocor Main Business Overview_x000D_
12.7.5 Eurocor Latest Developments_x000D_
12.8 Aachen Resonance_x000D_
12.8.1 Aachen Resonance Company Information_x000D_
12.8.2 Aachen Resonance Drug Eluting Balloons (DEB) Product Offered_x000D_
12.8.3 Aachen Resonance Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.8.4 Aachen Resonance Main Business Overview_x000D_
12.8.5 Aachen Resonance Latest Developments_x000D_
12.9 Biotronic_x000D_
12.9.1 Biotronic Company Information_x000D_
12.9.2 Biotronic Drug Eluting Balloons (DEB) Product Offered_x000D_
12.9.3 Biotronic Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.9.4 Biotronic Main Business Overview_x000D_
12.9.5 Biotronic Latest Developments_x000D_
_x000D_
13 Research Findings and Conclusion_x000D_
List of Tables_x000D_
Table 1. Drug Eluting Balloons (DEB) Consumption CAGR by Region (2020-2026) & ($ Millions)_x000D_
Table 2. Major Players of Peripheral DEBs_x000D_
Table 3. Major Players of Coronary DEBs_x000D_
Table 4. Global Drug Eluting Balloons (DEB) Sales by Type (2016-2021) & (K Units)_x000D_
Table 5. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2016-2021)_x000D_
Table 6. Global Drug Eluting Balloons (DEB) Revenue by Type (2016-2021) & ($ million)_x000D_
Table 7. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2016-2021)_x000D_
Table 8. Global Drug Eluting Balloons (DEB) Sale Price by Type (2016-2021)_x000D_
Table 9. Global Drug Eluting Balloons (DEB) Sales by Application (2016-2021) & (K Units)_x000D_
Table 10. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2016-2021)_x000D_
Table 11. Global Drug Eluting Balloons (DEB) Value by Application (2016-2021)_x000D_
Table 12. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2016-2021)_x000D_
Table 13. Global Drug Eluting Balloons (DEB) Sale Price by Application (2016-2021)_x000D_
Table 14. Global Drug Eluting Balloons (DEB) Sales by Company (2019-2021) & (K Units)_x000D_
Table 15. Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2019-2021)_x000D_
Table 16. Global Drug Eluting Balloons (DEB) Revenue by Company (2019-2021) ($ Millions)_x000D_
Table 17. Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2019-2021)_x000D_
Table 18. Global Drug Eluting Balloons (DEB) Sale Price by Company (2019-2021)_x000D_
Table 19. Key Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution and Sales Area_x000D_
Table 20. Players Drug Eluting Balloons (DEB) Products Offered_x000D_
Table 21. Drug Eluting Balloons (DEB) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)_x000D_
Table 22. New Products and Potential Entrants_x000D_
Table 23. Mergers & Acquisitions, Expansion_x000D_
Table 24. Global Drug Eluting Balloons (DEB) Sales by Region (2016-2021) (K Units)_x000D_
Table 25. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2016-2021)_x000D_
Table 26. Global Drug Eluting Balloons (DEB) Revenue by Region (2016-2021) & ($ Millions)_x000D_
Table 27. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2016-2021)_x000D_
Table 28. Americas Drug Eluting Balloons (DEB) Sales by Country (2016-2021) & (K Units)_x000D_
Table 29. Americas Drug Eluting Balloons (DEB) Sales Market Share by Country (2016-2021)_x000D_
Table 30. Americas Drug Eluting Balloons (DEB) Revenue by Country (2016-2021) & ($ Millions)_x000D_
Table 31. Americas Drug Eluting Balloons (DEB) Revenue Market Share by Country (2016-2021)_x000D_
Table 32. Americas Drug Eluting Balloons (DEB) Sales by Type (2016-2021) & (K Units)_x000D_
Table 33. Americas Drug Eluting Balloons (DEB) Sales Market Share by Type (2016-2021)_x000D_
Table 34. Americas Drug Eluting Balloons (DEB) Sales by Application (2016-2021) & (K Units)_x000D_
Table 35. Americas Drug Eluting Balloons (DEB) Sales Market Share by Application (2016-2021)_x000D_
Table 36. APAC Drug Eluting Balloons (DEB) Sales by Region (2016-2021) & (K Units)_x000D_
Table 37. APAC Drug Eluting Balloons (DEB) Sales Market Share by Region (2016-2021)_x000D_
Table 38. APAC Drug Eluting Balloons (DEB) Revenue by Region (2016-2021) & ($ Millions)_x000D_
Table 39. APAC Drug Eluting Balloons (DEB) Revenue Market Share by Region (2016-2021)_x000D_
Table 40. APAC Drug Eluting Balloons (DEB) Sales by Type (2016-2021) & (K Units)_x000D_
Table 41. APAC Drug Eluting Balloons (DEB) Sales Market Share by Type (2016-2021)_x000D_
Table 42. APAC Drug Eluting Balloons (DEB) Sales by Application (2016-2021) & (K Units)_x000D_
Table 43. APAC Drug Eluting Balloons (DEB) Sales Market Share by Application (2016-2021)_x000D_
Table 44. Europe Drug Eluting Balloons (DEB) Sales by Country (2016-2021) & (K Units)_x000D_
Table 45. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country (2016-2021)_x000D_
Table 46. Europe Drug Eluting Balloons (DEB) Revenue by Country (2016-2021) & ($ Millions)_x000D_
Table 47. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country (2016-2021)_x000D_
Table 48. Europe Drug Eluting Balloons (DEB) Sales by Type (2016-2021) & (K Units)_x000D_
Table 49. Europe Drug Eluting Balloons (DEB) Sales Market Share by Type (2016-2021)_x000D_
Table 50. Europe Drug Eluting Balloons (DEB) Sales by Application (2016-2021) & (K Units)_x000D_
Table 51. Europe Drug Eluting Balloons (DEB) Sales Market Share by Application (2016-2021)_x000D_
Table 52. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2016-2021) & (K Units)_x000D_
Table 53. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Country (2016-2021)_x000D_
Table 54. Middle East & Africa Drug Eluting Balloons (DEB) Revenue by Country (2016-2021) & ($ Millions)_x000D_
Table 55. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country (2016-2021)_x000D_
Table 56. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type (2016-2021) & (K Units)_x000D_
Table 57. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Type (2016-2021)_x000D_
Table 58. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application (2016-2021) & (K Units)_x000D_
Table 59. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Application (2016-2021)_x000D_
Table 60. Key and Potential Regions of Drug Eluting Balloons (DEB)_x000D_
Table 61. Key Application and Potential Industries of Drug Eluting Balloons (DEB)_x000D_
Table 62. Key Challenges of Drug Eluting Balloons (DEB)_x000D_
Table 63. Key Trends of Drug Eluting Balloons (DEB)_x000D_
Table 64. Drug Eluting Balloons (DEB) Distributors List_x000D_
Table 65. Drug Eluting Balloons (DEB) Customer List_x000D_
Table 66. Global Drug Eluting Balloons (DEB) Sales Forecast by Region (2021-2026) & (K Units)_x000D_
Table 67. Global Drug Eluting Balloons (DEB) Consumption Market Forecast by Region_x000D_
Table 68. Global Drug Eluting Balloons (DEB) Revenue Forecast by Region (2021-2026) & ($ millions)_x000D_
Table 69. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Region (2021-2026)_x000D_
Table 70. Americas Drug Eluting Balloons (DEB) Sales Forecast by Country (2021-2026) & (K Units)_x000D_
Table 71. Americas Drug Eluting Balloons (DEB) Revenue Forecast by Country (2021-2026) & ($ millions)_x000D_
Table 72. APAC Drug Eluting Balloons (DEB) Sales Forecast by Region (2021-2026) & (K Units)_x000D_
Table 73. APAC Drug Eluting Balloons (DEB) Revenue Forecast by Region (2021-2026) & ($ millions)_x000D_
Table 74. Europe Drug Eluting Balloons (DEB) Sales Forecast by Country (2021-2026) & (K Units)_x000D_
Table 75. Europe Drug Eluting Balloons (DEB) Revenue Forecast by Country (2021-2026) & ($ millions)_x000D_
Table 76. Middle East & Africa Drug Eluting Balloons (DEB) Sales Forecast by Country (2021-2026) & (K Units)_x000D_
Table 77. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Forecast by Country (2021-2026) & ($ millions)_x000D_
Table 78. Global Drug Eluting Balloons (DEB) Sales Forecast by Type (2021-2026) & (K Units)_x000D_
Table 79. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Type (2021-2026)_x000D_
Table 80. Global Drug Eluting Balloons (DEB) Revenue Forecast by Type (2021-2026) & ($ Millions)_x000D_
Table 81. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Type (2021-2026)_x000D_
Table 82. Global Drug Eluting Balloons (DEB) Sales Forecast by Application (2021-2026) & (K Units)_x000D_
Table 83. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Application (2021-2026)_x000D_
Table 84. Global Drug Eluting Balloons (DEB) Revenue Forecast by Application (2021-2026) & ($ Millions)_x000D_
Table 85. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Application (2021-2026)_x000D_
Table 86. B. Braun Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 87. B. Braun Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 88. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 89. B. Braun Main Business_x000D_
Table 90. B. Braun Latest Developments_x000D_
Table 91. Medtronic Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 92. Medtronic Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 93. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 94. Medtronic Main Business_x000D_
Table 95. Medtronic Latest Developments_x000D_
Table 96. Boston Scientific Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 97. Boston Scientific Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 98. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 99. Boston Scientific Main Business_x000D_
Table 100. Boston Scientific Latest Developments_x000D_
Table 101. BD Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 102. BD Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 103. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 104. BD Main Business_x000D_
Table 105. BD Latest Developments_x000D_
Table 106. Yinyi Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 107. Yinyi Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 108. Yinyi Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 109. Yinyi Main Business_x000D_
Table 110. Yinyi Latest Developments_x000D_
Table 111. Philips Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 112. Philips Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 113. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 114. Philips Main Business_x000D_
Table 115. Philips Latest Developments_x000D_
Table 116. Eurocor Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 117. Eurocor Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 118. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 119. Eurocor Main Business_x000D_
Table 120. Eurocor Latest Developments_x000D_
Table 121. Aachen Resonance Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 122. Aachen Resonance Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 123. Aachen Resonance Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 124. Aachen Resonance Main Business_x000D_
Table 125. Aachen Resonance Latest Developments_x000D_
Table 126. Biotronic Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 127. Biotronic Drug Eluting Balloons (DEB) Product Offered_x000D_
Table 128. Biotronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)_x000D_
Table 129. Biotronic Main Business_x000D_
Table 130. Biotronic Latest Developments_x000D_
List of Figures_x000D_
Figure 1. Picture of Drug Eluting Balloons (DEB)_x000D_
Figure 2. Drug Eluting Balloons (DEB) Report Years Considered_x000D_
Figure 3. Research Objectives_x000D_
Figure 4. Research Methodology_x000D_
Figure 5. Research Process and Data Source_x000D_
Figure 6. Global Drug Eluting Balloons (DEB) Sales Growth Rate 2016-2026 (K Units)_x000D_
Figure 7. Global Drug Eluting Balloons (DEB) Revenue Growth Rate 2016-2026 ($ Millions)_x000D_
Figure 8. Drug Eluting Balloons (DEB) Sales by Region (2021 & 2026) & ($ millions)_x000D_
Figure 9. Product Picture of Peripheral DEBs_x000D_
Figure 10. Product Picture of Coronary DEBs_x000D_
Figure 11. Global Drug Eluting Balloons (DEB) Sales Market Share by Type in 2020_x000D_
Figure 12. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2016-2021)_x000D_
Figure 13. Drug Eluting Balloons (DEB) Consumed in Catheterization Laboratory_x000D_
Figure 14. Global Drug Eluting Balloons (DEB) Market: Catheterization Laboratory (2016-2021) & (K Units)_x000D_
Figure 15. Drug Eluting Balloons (DEB) Consumed in Hospital_x000D_
Figure 16. Global Drug Eluting Balloons (DEB) Market: Hospital (2016-2021) & (K Units)_x000D_
Figure 17. Drug Eluting Balloons (DEB) Consumed in Others_x000D_
Figure 18. Global Drug Eluting Balloons (DEB) Market: Others (2016-2021) & (K Units)_x000D_
Figure 19. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2016-2021)_x000D_
Figure 20. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application in 2020_x000D_
Figure 21. Drug Eluting Balloons (DEB) Revenue Market by Company in 2020 ($ Million)_x000D_
Figure 22. Global Drug Eluting Balloons (DEB) Revenue Market Share by Company in 2020_x000D_
Figure 23. Global Drug Eluting Balloons (DEB) Sales Market Share by Regions (2016-2021)_x000D_
Figure 24. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region in 2020_x000D_
Figure 25. Americas Drug Eluting Balloons (DEB) Sales 2016-2021 (K Units)_x000D_
Figure 26. Americas Drug Eluting Balloons (DEB) Revenue 2016-2021 ($ Millions)_x000D_
Figure 27. APAC Drug Eluting Balloons (DEB) Sales 2016-2021 (K Units)_x000D_
Figure 28. APAC Drug Eluting Balloons (DEB) Revenue 2016-2021 ($ Millions)_x000D_
Figure 29. Europe Drug Eluting Balloons (DEB) Sales 2016-2021 (K Units)_x000D_
Figure 30. Europe Drug Eluting Balloons (DEB) Revenue 2016-2021 ($ Millions)_x000D_
Figure 31. Middle East & Africa Drug Eluting Balloons (DEB) Sales 2016-2021 (K Units)_x000D_
Figure 32. Middle East & Africa Drug Eluting Balloons (DEB) Revenue 2016-2021 ($ Millions)_x000D_
Figure 33. Americas Drug Eluting Balloons (DEB) Sales Market Share by Country in 2020_x000D_
Figure 34. Americas Drug Eluting Balloons (DEB) Revenue Market Share by Country in 2020_x000D_
Figure 35. Americas Drug Eluting Balloons (DEB) Sales Market Share by Type in 2020_x000D_
Figure 36. Americas Drug Eluting Balloons (DEB) Sales Market Share by Application in 2020_x000D_
Figure 37. United States Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 38. Canada Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 39. Mexico Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 40. Brazil Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 41. APAC Drug Eluting Balloons (DEB) Sales Market Share by Region in 2020_x000D_
Figure 42. APAC Drug Eluting Balloons (DEB) Revenue Market Share by Regions in 2020_x000D_
Figure 43. APAC Drug Eluting Balloons (DEB) Sales Market Share by Type in 2020_x000D_
Figure 44. APAC Drug Eluting Balloons (DEB) Sales Market Share by Application in 2020_x000D_
Figure 45. China Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 46. Japan Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 47. Korea Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 48. Southeast Asia Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 49. India Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 50. Australia Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 51. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country in 2020_x000D_
Figure 52. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country in 2020_x000D_
Figure 53. Europe Drug Eluting Balloons (DEB) Sales Market Share by Type in 2020_x000D_
Figure 54. Europe Drug Eluting Balloons (DEB) Sales Market Share by Application in 2020_x000D_
Figure 55. Germany Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 56. France Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 57. UK Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 58. Italy Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 59. Russia Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 60. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Country in 2020_x000D_
Figure 61. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country in 2020_x000D_
Figure 62. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Type in 2020_x000D_
Figure 63. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Application in 2020_x000D_
Figure 64. Egypt Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 65. South Africa Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 66. Israel Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 67. Turkey Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 68. GCC Country Drug Eluting Balloons (DEB) Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 69. Channels of Distribution_x000D_
Figure 70. Distributors Profiles_x000D_
